Table 1 Baseline clinical and laboratory characteristics according to the presence of vasospastic angina (VA)
Patients without VA (n = 676) | Patients with VA (n = 300) | p-value | |
|---|---|---|---|
Age, years | 53.2 ± 10.9 | 55.7 ± 9.8 | <0.001 |
Male gender, n (%) | 278 (41.1%) | 186 (62%) | <0.001 |
Body mass index, kg/m2 | 24.6 ± 3.3 | 24.7 ± 3.2 | 0.681 |
systolic BP, mmHg | 147.3 ± 24.1 | 148.2 ± 24.1 | 0.568 |
diastolic BP, mmHg | 74.1 ± 13.2 | 74.3 ± 12.4 | 0.784 |
Current smoking, n (%) | 159 (23.5%) | 135 (45%) | <0.001 |
Alcohol drinker, n (%) | 216 (32%) | 124 (41.3%) | 0.006 |
Diabetes mellitus, n (%) | 78 (11.6%) | 49 (16.3%) | 0.052 |
Dyslipidemia, n (%) | 287 (42.5%) | 156 (52%) | 0.007 |
Hypertension, n (%) | 200 (29.6%) | 90 (30%) | 0.956 |
Hyperthyroidism, n (%) | 28 (7.5%) | 8 (5.3%) | 0.466 |
Previous medication | |||
Aspirin | 106 (15.8%) | 44 (14.7%) | 0.752 |
RAS blocker | 89 (13.2%) | 52 (17.3%) | 0.109 |
Beta blocker | 67 (9.9%) | 36 (12%) | 0.390 |
Calcium channel blocker | 91 (13.5%) | 45 (15%) | 0.601 |
Diuretics | 19 (2.8%) | 9 (3%) | 1.000 |
Nitrates | 65 (9.7%) | 44 (14.7%) | 0.029 |
Statin | 83 (12.4%) | 57 (19%) | 0.009 |
Uric acid, mg/L | 5.4 ± 1.5 | 5.5 ± 1.5 | 0.492 |
Creatinine, mg/dL | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.973 |
Fasting glucose, mg/dL | 101.9 ± 24.9 | 98.6 ± 19.5 | 0.054 |
Total cholesterol, mg/dL | 176.5 ± 37.1 | 174.2 ± 35.3 | 0.375 |
LDLcholesterol, mg/dL | 105.2 ± 36.0 | 103.1 ± 31.2 | 0.391 |
HDL cholesterol, mg/dL | 47.7 ± 14.5 | 47.3 ± 13.0 | 0.647 |
Triglycerides, mg/dL | 124.7 ± 120.1 | 131.6 ± 103.4 | 0.386 |
hs-CRP, mg/dL | 0.3 ± 1.0 | 0.3 ± 1.3 | 0.973 |